AGG Talks: Government Insight for Life Sciences Leaders | How Medicare Regulations Could Affect Access to Gender-Affirming Care: Implications for Life Sciences Companies
42 CFR Part 2 Final Rule: What’s Changing and What Do You Need to Know? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 257: Biogen’s $2B Investment in North Carolina’s RTP with Nicole Murphy
Hospice Insights Podcast - If Only I Knew… Avoiding the Most Common Mistakes with the 855
H-1B Enforcement Tightened, Fertility Benefits Expanded, Gender Identity Protection Setback - #WorkforceWednesday® - Employment Law This Week®
Workplace Mental Health: Strategies for Stress and Anxiety Relief
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 256: AI, Advocacy & Clinical Trials with Sophia McLeod of ACRO
Current Tailwinds in Women’s Health - What Do They Mean for Your Business? – Diagnosing Health Care Video Podcast
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 255: Private Equity Essentials for Life Sciences Organizations and Startups
The IP Future: Intellectual Property Challenges in AI Health Care Contracts – The Good Bot: Artificial Intelligence, Health Care, and the Law
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 254: Responsible AI in Healthcare with Dr. Justin Collier of Lenovo
What's New with the False Claims Act?
Hospice Insights Podcast - Making Palliative Care a Win-Win-Win: A Conversation with Dr. Bethany Snider, Chief Medical Officer, Hosparus Health
Exploring Long-Term Home Care Solutions with Albert Eshoo & Joyce Barocas
Employee Benefits and Executive Compensation Preparing for 2026 – Top Five Health and Welfare Updates — Troutman Pepper Podcast
AGG Talks: Government Insight for Life Sciences Leaders - Episode 2: DOJ’s Shifting Enforcement: CPB Disbanding, Counterfeit Drug Focus, and Gender-Affirming Care Investigations
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 253: The Rise of Ambulatory Surgery Centers with Mark Wainner of ASCA
FTC Backs Off Non-Compete Ban, Warns Health Care Employers - #WorkforceWednesday® - Employment Law This Week®
The Latest on Value Based Care
Navigating Women's Health with Rachel Welch
On Nov. 12, 2025, the president signed into law three appropriations bills to partially fund the government for the rest of fiscal year 2026 through Sept. 30, 2026, and a continuing resolution to fund the rest of the...more
Kick-start your compliance education with this comprehensive workshop - HCCA’s four-day Healthcare Compliance Essentials Workshop is designed to provide foundational education on the key elements of a compliance program...more
Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the big story is the impending demise of the hemp industry. In addition, the state of Nebraska is feuding...more
On November 12, 2025, the congressional package to reopen the government was approved by both legislative chambers and has been signed into law by the president. While most of the nation breathes a collective sigh of relief,...more
In this episode, AGG Life Sciences co-chair Alan Minsk and Healthcare partner Andrew Tsui examine how the Centers for Medicare & Medicaid Services ("CMS") may apply the Medicare Conditions of Participation ("COPs") to...more
Background- The case involved an owner and operator of pharmacies charged with healthcare fraud and kickback charges based on alleged participation in a drug diversion scheme. Before deliberations began, the district court...more
Alabama AG Steve Marshall obtained a temporary restraining order against Aurora IV and Wellness, an infusion clinic, and its owners in a case alleging that they administered research-grade weight loss drugs without patients’...more
Since May, the Trump administration has used tariffs and Most Favored Nation (MFN) drug pricing threats as a means to pressure pharmaceutical manufacturers to lower drug prices in the U.S. This pressure culminated in a...more
On November 4, 2025, Sen. Bill Cassidy (R-LA) introduced the Health Information Privacy Reform Act (the Act), which would, among other things, expand the privacy protections of the Health Insurance Portability and...more
The Food and Drug Administration (FDA) has issued new draft guidance signaling a policy shift toward reducing the need for comparative efficacy (CES) studies in biosimilar applications. The FDA’s approach aims to accelerate...more
Key Takeaways: The US Food and Drug Administration (FDA) is proposing a new “plausible mechanism” pathway that will enable the limited approval of bespoke therapies when randomized trials are impractical....more
On 5 November the Singapore Ministry of Health introduced the Health Information Bill (the “Bill”) in Parliament, marking a major step towards achieving a centralised digital health ecosystem in Singapore. If enacted, the...more
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced its intention to introduce sweeping reforms for accelerating rare disease therapy development and approval, with the aim to position the UK as a...more
Most physicians and the providers to whom they make referrals understand the importance of complying with the Stark Law as well as how costly non-compliance can be. However, many providers are often surprised to learn that...more
The end of the longest government shutdown in US history is finally here, with the president having signed a continuing resolution (CR) that funds the government through January 30, 2026....more
Effective January 1, 2026, a new law — Assembly Bill 1501 — will amend Section 3516 of the California Business and Professions Code to allow physicians to supervise up to eight physician assistants (PAs) at any one time in...more
CMS is launching a five-year Prior Authorization Demonstration for certain ambulatory surgical center (ASC) services beginning December 15, 2025, in 10 states, including Georgia, Florida, Tennessee, and Texas....more
Bass, Berry & Sims hosted the 15th annual Health Care Investors Conference (HCIC), co-sponsored by Deloitte, Gallagher and Houlihan Lokey, on October 29. Each year HCIC brings together hundreds of leading health care industry...more
The Internal Revenue Service (IRS) has announced the cost-of-living adjustments to the applicable dollar limits for various employer-sponsored retirement and welfare plans for 2026....more
By early 2026, substance use disorder (SUD) providers, health plans, clinicians, health information exchanges (HIEs), and vendors must meet new federal privacy standards for SUD treatment records or face Health Insurance...more
The third quarter of 2025 closed amid growing macroeconomic strain, policy unpredictability and renewed investor focus on execution risk. While deal volume in life sciences and healthcare private capital has stabilized after...more
On October 31, CMS finalized the CY 2026 Medicare Physician Fee Schedule (PFS) rule (CMS-1832-F), effective January 1, 2026. While primarily directed at Medicare providers, the rule’s changes have clear downstream effects for...more
The U.S. Food and Drug Administration (FDA) significantly revised its approach to biosimilar drug development on October 29. Specifically, FDA issued a draft guidance recommending when comparative analytical assessments (CAA)...more
On October 31, the Centers for Medicare & Medicaid Services (CMS) issued a final rule announcing changes for Medicare payments under the Physician Fee Schedule (PFS), effective on or after January 1, 2026....more
The Commonwealth of Pennsylvania’s Department of Labor & Industry and 16 other state Attorney Generals and/or labor departments collectively submitted November 1st comments to the Occupational Safety and Health Administration...more
